🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $SENEA and executed a BUY strategy, securing a +19.05% net profit.

UPGRADE TO SEE LIVE SIGNALS

$TCRX

Tscan Therapeutics Inc

United StatesUNITED STATES
FREE PREVIEW
AVG HISTORICAL GAP0.46%
MAX GAP RECORD25.29%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY4.0%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts. The company was founded by Christoph H. Westphal, Stephen Elledge, Lea Hachigian, and Tomasz Kula in 2018… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL